For instance, increased nectin-4 expression has been noted in a subset of cutaneous adnexal carcinomas, particularly sebaceous carcinomas, indicating that EV may be a promising treatment for these tumors (Ingen-Housz-Oro et al., 2024; Cho et al., 2024). The gene discussed is NECTIN4; the disease is sebaceous adenocarcinoma.